| Identification | Back Directory | [Name]
4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile | [CAS]
236750-65-5 | [Synonyms]
Erlotinib-12
Erlotinib Impurity W
Erlotinib interMediate
Erlotinib intermediates
Erlotinib impurities403
Azilsartan medoxomil impurity245
Erlotinib Hydrochloride iMpurity 11
Erlotinib Hydrochloride iMpurity 16
4,5-Bis(2-methoxy)-2-nitrobenzonitrile
4,5-Di(2-methoxyethoxy)-2-nitrobenzonitrile
4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile
2-nitro-4,5-bis(2-Methoxyethoxy)benzonitrile
Benzonitrile, 4,5-bis(2-methoxyethoxy)-2-nitro-
4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile USP/EP/BP
4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile 236750-65-5 | [EINECS(EC#)]
1308068-626-2 | [Molecular Formula]
C13H16N2O6 | [MDL Number]
MFCD17676647 | [MOL File]
236750-65-5.mol | [Molecular Weight]
296.28 |
| Hazard Information | Back Directory | [Uses]
4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile is an impurity of Erlotinib (E625008), a EGFR-targeted drug in the treatment of non-small cell lung cancer. EGFR small tyrosine kinase inhibitor that shows most substantial effect on tumor growth inhibition and animal survival. |
|
|